🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📺 How can #AI speed up the time it takes to identify, design and create a transformative #biotech product? Cradle’s Stef van Grieken has a few thoughts on how to reduce barriers to entry, and production… 🔗 hubs.la/Q027jrvP0

We’re delighted to be recognised in the inaugural FORTUNE 50 AI innovators power list, for our #AI-powered drug discovery process, which we’re using to find faster and smarter ways to discover new and better drug candidates. fortune.com/ranking/ai-inn…

💰 I'm proud to announce we have raised a $24M Series A! We Cradle are building an AI to design proteins. Why? Because designing proteins is the first step towards replacing factories 🏭 and farms 🐄 for a more sustainable future. Let's 🧵 ❤️ = retweet/like/comment

During my PhD with Frances Arnold Caltech we taught nature to break man-made bonds. Excited to share our report in @sciencemagazine using #directedevolution to engineer the first #enzyme that can cleave silicon–carbon bonds in non-biodegradable siloxanes! science.org/doi/10.1126/sc…

Cannot Be Unseen

We've had a makeover! If you head to our website, things look a bit... different ✨ It's now easier to find out more about different parts of the platform, and for you to get in touch with us. Check it out: animahealth.com

Exciting news. Today we welcome Anima into our portfolio, as they announce a $12m Series A, led by Molten. Congratulations team! moltenventures.com/news/molten-ve…

The new Serna Bio website goes live today. To celebrate the launch we're revisiting our STaR rules work one year on - thanks Tim Allen. Take a look at the site and catch up on our progress here: serna.bio

👋👋👋 Bonjour

We are excited to announce the launch of Seqera AI, making it easier than ever to access and utilize advanced bioinformatics tools effectively! 🎉 👉Read the blog to find out more: hubs.la/Q02Wq_1T0

This one is special… We have advanced our first drug into Phase 1 clinical trials! ENV-294 is a first-in-class small molecule with exciting potential to treat atopic dermatitis (commonly known as eczema) – an underserved and devastating inflammatory condition that impacts more

We’re thrilled to announce $130M in Series C funding led by Kinnevik AB and FPV, with participation from Baillie Gifford , Premji Invest , Lux Capital , True Ventures , and many more new and existing partners. With this new capital, we plan to advance multiple drug candidates

💰 I'm proud to announce that we have raised a $73M Series B! We have now raised a bit more than $100M to make it easier to engineer proteins. Why Proteins? To replace traditional chemical factories 🏭 and farms 🐄 for a more sustainable future. RT / Like / Comment = ❤️

Starting JPM STRONG! Thanks to all the founders and co-investors who showed up early at the red room to kick off the JPM week! Workout co-hosted by Atria Ventures and Amino Collective

Lindus Health raises $55M to ‘fix the broken clinical trial industry’ tcrn.ch/4h2pBDH

Big congratulations to Meri Beckwith, Michael Young and team for adding more fuel to an incredibly important mission: fixing the broken clinical trial industry!

🚀 Big news! @ExpressionEdits teams up with Boehringer Ingelheim to bring first-in-class gene therapies to patients. With our AI-powered Genetic Syntax Engine & #intronization tech, we’re boosting potency, reducing viral loads, and enabling targeted treatments. #biotechnews

Pillar VC and Amino Collective have joined as partners for the 2025 Nucleate Venture Fellowship. Fellows will conduct due diligence on startups, collaborate with investors, and receive mentorship to accelerate their careers in VC. Apply by March 7th: loom.ly/UgS2h_0

To continue advancing the vision that scientific innovation runs on software, we are thrilled to announce that Seqera has closed it’s Series B funding, led by Addition with participation from Speedinvest, Talis, Amino Collective, BoxOne Ventures, and SNR! 🎉 Learn more:

I’m excited to share that Inductive Bio has raised a $25M Series A to transform small molecule drug discovery with AI. Grateful to Obvious Ventures, a16z Bio + Health, @Lux, @S32, Character, Amino Collective & our amazing team. inductive.bio/news/inductive…